Search hospitals > California > Santa Monica
Sarcoma Oncology Center
Claim this profileSanta Monica, California 90403
Global Leader in Soft Tissue Sarcoma
Global Leader in Solid Tumors
Conducts research for Cancer
Conducts research for Pancreatic Cancer
Conducts research for Sarcoma
121 reported clinical trials
10 medical researchers
Summary
Sarcoma Oncology Center is a medical facility located in Santa Monica, California. This center is recognized for care of Soft Tissue Sarcoma, Solid Tumors, Cancer, Pancreatic Cancer, Sarcoma and other specialties. Sarcoma Oncology Center is involved with conducting 121 clinical trials across 143 conditions. There are 10 research doctors associated with this hospital, such as Victoria Chua-Alcala, MD, Sant P Chawla, MD, Victoria Chua, MD, and Erlinda M Gordon, MD.Area of expertise
1Soft Tissue Sarcoma
Global LeaderStage IV
Stage III
AXL positive
2Solid Tumors
Global LeaderStage IV
Stage III
AXL positive
Top PIs
Victoria Chua-Alcala, MDSarcoma Oncology Research Center7 years of reported clinical research
Expert in Soft Tissue Sarcoma
Expert in Solid Tumors
44 reported clinical trials
63 drugs studied
Sant P Chawla, MDSarcoma Oncology Center3 years of reported clinical research
Expert in Soft Tissue Sarcoma
Studies Solid Tumors
42 reported clinical trials
59 drugs studied
Victoria Chua, MDSarcoma Oncology Center4 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Cancer
8 reported clinical trials
13 drugs studied
Erlinda M Gordon, MDSarcoma Oncology Research Center8 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Chordoma
5 reported clinical trials
6 drugs studied
Clinical Trials running at Sarcoma Oncology Center
Soft Tissue Sarcoma
Solid Tumors
Breast Cancer
Colorectal Cancer
Cancer
Sarcoma
Giant Cell Tumor
Lung Cancer
Liposarcoma
Solitary Fibrous Tumor
Combination Therapy
for Sarcoma
This is a Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin as first, second or third line therapy for advanced sarcoma, including desmoid tumor and chordoma.
Recruiting3 awards Phase 2
Lurbinectedin + Immunotherapy
for Soft Tissue Sarcoma
This is an open label, dose-seeking phase 1/2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIMUMAB and NIVOLUMAB administered intravenously.
Recruiting1 award Phase 1 & 2
Trabectedin + Immunotherapy
for Soft Tissue Sarcoma
This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB based on preliminary results of the Checkmate 012 trial for NSCLC (Hellman et al., 2016). For the Phase 1 Part of Study, only previously treated patients will be enrolled. For the Phase 2 Part of Study, previously treated patients will be enrolled.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarcoma Oncology Center?
Sarcoma Oncology Center is a medical facility located in Santa Monica, California. This center is recognized for care of Soft Tissue Sarcoma, Solid Tumors, Cancer, Pancreatic Cancer, Sarcoma and other specialties. Sarcoma Oncology Center is involved with conducting 121 clinical trials across 143 conditions. There are 10 research doctors associated with this hospital, such as Victoria Chua-Alcala, MD, Sant P Chawla, MD, Victoria Chua, MD, and Erlinda M Gordon, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.